Table 1.
Demographic and clinical characteristics of the study patients (n = 121)
| Gender | |
| Male, n (%) | 51 (42.1) |
| Female, n (%) | 70 (57.9) |
| Age (yr) | |
| Mean ± SD | 42.2 ± 15.1 |
| Range | 14-84 |
| Month of the bite | |
| March, n (%) | 1 (0.8) |
| April, n (%) | 8 (6.6) |
| May, n (%) | 10 (8.3) |
| June, n (%) | 20 (16.5) |
| July, n (%) | 16 (13.2) |
| August, n (%) | 22 (18.2)) |
| September, n (%) | 29 (24) |
| October, n (%) | 10 (8.3) |
| November, n (%) | 5 (4.1) |
| Duration at arrival (d) | |
| Mean ± SD | 3.4 ± 3.7a |
| Median | 3 |
| Range | 1-30 |
| Duration of hospital stay (d) | |
| Mean ± SD | 12.4 ± 7.7a |
| Median | 10 |
| Range | 1-40 |
| Bite site | |
| Lower limb, n (%) | 75 (85.2) |
| Upper limb, n (%) | 13 (14.8) |
| Oliguria, n (%) | 70 (79.5)a |
| Hematuria, n (%) | 48 (54.5)a |
| Limb swelling/cellulitis, n (%) | 12 (13.6)a |
| Neurotoxicity, n (%) | 5 (5.7)a |
| Coagulation defect, n (%) | 78 (88.6)a |
| ASV given, n (%) | 85 (96.6)a |
| Blood transfusion, n (%) | 15 (17)a |
| ICU support, n (%) | 10 (11.4)a |
| Dialysis therapy, n (%) | 99 (81.8) |
| Hemodialysis | |
| Mean ± SD | 3.5 ± 3.7 |
| Median | 3 |
| Range | 1-20 |
| Outcome | |
| Survived, n (%) | 110 (90.9) |
| Died, n (%) | 11 (9.1) |
a
Clinical details avaiable in 88 patients. ASV: Anti-snake venom; ICU: Intensive care unit.